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Abstract: Nuclear protein 1 (NUPR1) is a transcription cofactor that senses stressful conditions and 
modulates cellular response by promoting or inhibiting apoptosis. NUPR1 is usually highly expressed 
in tumor cells where it enables them to adapt and resist environmental stress or chemotherapeutic 
compounds. NUPR1 can be involved in cell proliferation. Data about the involvement of NUPR1 in 
the proliferation and apoptosis of lymphocytes are scarce. Therefore, in this study we focused on the 
role of NUPR1 in lymphocyte physiology and found that NUPR1 might be involved in the initiation of 
their proliferation. Lymphocytes were isolated from the cervical lymph nodes of C57BL/6 mice. 
NUPR1 expression subsided 24 h after the induction of proliferation by a mitogen. Also, stressful 
conditions after cell isolation led to increased NUPR1 mRNA and protein expression in vitro that 
coincided with cell apoptosis. Similarly, apoptosis induction by staurosporine, a broad-range protein 
kinase inhibitor, led to increased NUPR1 expression. In addition, NUPR1 inhibition by small-
interfering RNA prevented the staurosporine-induced apoptosis (judging from decreased caspase 
activity) in the whole cell population of cervical lymph nodes. However, NUPR1 absence was 
irrelevant to the induction of apoptosis in CD3
+
 T lymphocytes, suggesting that NUPR1 is probably a 
mediator of apoptosis in other immune cell populations within the lymph node, such as B 
lymphocytes. In conclusion, our results suggest that NUPR1 is important for the initiation of 
lymphocyte cell division and for the apoptotic process of non-T cells during stressful conditions. 
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INTRODUCTION 
Nuclear protein 1 (NUPR1) is a small chromatin protein that senses stress signals from the 
environment and enables cells to adapt and to resist apoptosis. NUPR1 is a protein of 8 kDa 
(hence its other name, p8) that can interfere with histone modifications and bind to gene 
promoters, thereby modulating gene expression. NUPR1 is important for the resistance of 
tumor cells to apoptosis induction since it specifically leads to the transactivation of the 
immediate early response 3 (Ier3) gene in pancreatic cancer cells that protects cells from Fas- 
or tumor necrosis factor (TNF)-induced apoptosis [1]. Also, NUPR1 binds thymosin and 
interferes with the apoptotic cascade in HeLa cells. The absence of NUPR1 renders HeLa 
cells susceptible to staurosporine-induced apoptosis [2]. Therefore, it is not surprising that 
elevated NUPR1 expression is found in breast cancer cells, pancreatic carcinoma cells and 
adenocarcinoma [3,4]. In breast cancer cells, the overexpression of NUPR1 leads to the 
activation of the phosphatidylinositide 3-kinase (PI3K)/Protein kinase B (PKB) (Akt) 
signaling pathway, cyclin-dependent kinase inhibitor 1 (CDKN1A; p21
Cip1
) phosphorylation 
and relocalization from the nucleus to the cytoplasm that enables malignant cells to resist the 
action of chemotherapeutics. The involvement of NUPR1 in the malignant process is further 
confirmed by the fact that transforming growth factor  (TGF-), a cytokine involved in 
tumorigenesis, stimulates NUPR1 expression [5]. Obviously, this prosurvival function of 
NUPR1 supports cancer progression. However, NUPR1 can have a completely opposite role 
in the regulation of apoptosis since it can promote autophagy-induced apoptosis via the 
inhibition of Akt/mammalian target of rapamycin complex-1 (mTORC1) signaling after 
sensing stress-induced changes in the endoplasmic reticulum [6, 7]. NUPR1 might also have a 
role in the control of cell proliferation since its complete deletion increases pancreatic β-cell 
proliferation [8]. Also, NUPR1 negatively regulates the proliferation of myocytes and 
promotes myogenic differentiation [9,10]. As regards immune cells, it was shown that the 
number of all immune cells is comparable between NUPR1
-/-
 and NUPR1
+/+
, though the 
apoptosis rate under normal and inflammatory conditions is increased in the absence of 
NUPR1, especially in CD3
+
 cells [11]. 
To date, there are no data about the role of NUPR1 in the proliferation and stress-
induced apoptosis of immune cells. Therefore, in this study we investigated the correlation of 
NUPR1 mRNA and protein expression and mitogen-triggered immune cell proliferation or 
apoptosis induced either by the process of cell isolation or by staurosporine, a broad-spectrum 
protein kinase inhibitor. 
 
MATERIALS AND METHODS 
Animals 
Female C57BL/6 mice were bred and kept in the animal facility of Institute for Biological 
Research “Siniša Stanković”, and their use and all experimental procedures were approved by 
the Ethics Committee of the Institute (App. No 01-07/15), which are in accordance with 
Directive 2010/63/EU. The mice were maintained under standard conditions with a 12-h 
day/night rhythm and fed with standard rodent chow and water. 
Isolation of lymphocytes from cervical lymph nodes 
C57BL/6 mice (8-12 weeks of age) were euthanized by CO2 affixation and cervical lymph 
nodes were collected in tubes filled with phosphate-buffered saline (PBS). Lymph nodes were 
passed through 40-μm cell strainers and dispersed into a single cell suspension. After 
centrifugation at 500 g for 5 min, cervical lymph node cells (CLNC) were resuspended in 
RPMI-1640 medium containing 25 mM HEPES, 2 mM L-glutamine, 5% FCS (PAA 
Chemicals, Pasching, Austria), penicillin/streptomycin (Sigma-Aldrich, St. Luis, MO, USA) 
and 5 µM β-mercaptoethanol, counted by trypan blue exclusion test (Sigma-Aldrich) and 
placed in 24-well plates at 37°C in a 5% CO2 incubator. CLNC were cultured in the media 
alone or in the presence of 1 μg/mL concanavalin A (ConA), or with 1 μM staurosporine 
(Sigma-Aldrich). 
CD3
+
 lymphocyte purification 
CLNC (1 x 10
7
) were resuspended in 5 mL of RPMI-1640 and 10% FCS. For separation of 
adherent and nonadherent cells, a column made of nylon wool was soaked first in 5 mL of 
medium (RPMI-1640 and 10% FCS) and the resuspended cells were overlaid. The column 
with cells was maintained for 1 h at 37°C in a 5% CO2 incubator and nonadherent cells were 
eluted with warm medium (2 x 5 mL). The recovery of cells was about 2x10
6
; the purity of 
CD3
+
 cells was 92.2±8.2% (determined by flow cytometry analysis). 
NUPR1 inhibition by small interfering RNA (siRNA) 
In a 24-well tissue culture plate, 1×10
6
 CLNC were placed in 1 mL of antibiotic-free medium 
supplemented with 10% FCS. After overnight incubation, the cells were transfected according 
to the manufacturer’s instructions (SantaCruz Biotechnology Inc., Santa Cruz, CA, USA). 
Briefly, incubation in transfection medium containing NUPR1 or control small-interfering 
RNA (siRNA) lasted for 6 h. The cells were then washed and placed in RPMI-1640 medium 
with 10% FCS and antibiotics. After overnight incubation (18 h), 1 μM staurosporine was 
applied for 3 h before the cells were collected and their apoptosis was measured by 
determining caspase activity by flow cytometry. Transfected CLNC were also challenged for 
24 h with ConA and proliferation was measured by the 3-(4,5-dimethyl-2-thiazolyl)-2-5-
diphenyl-2H-tetrazolium bromide (MTT) assay. 
Apoptosis detection 
After the above treatments, CLNC were stained with FITC-annexin V (BD Pharmingen, San 
Diego, CA, USA) and propidium iodide (Life Technologies Ltd, Paisley, UK) (10 ng/mL) for 
10 min at room temperature in the dark in the specific annexin-binding buffer, washed in the 
same buffer and analyzed on a Partec CyFlowSpace flow cytometer by FlowMax software 
(Partec, GmbH, Münster, Germany). To detect cells with active caspases (an indicator of 
apoptosis), CLNC were stained with Apostat (pan-caspase inhibitor) (1:100) (R&D, 
Minneapolis, MN, USA) for 30 min at 37°C in a 5% CO2 incubator, washed in PBS and 
analyzed on the flow cytometer. 
Proliferation assay 
After 24 h of treatment with ConA, control CLNC or siRNA NUPR1-transfected CLNC were 
treated with MTT solution (0.5 mg/ml) for 2 h at 37°C in a 5% CO2 incubator. In the presence 
of oxygen derived from mitochondria MTT is reduced to dark formazan crystals, serving as 
an indicator of cell respiration and indirectly, of cell number and proliferation [12]. The 
formazan crystals were then dissolved in DMSO. The absorbance was measured in an 
automated microplate reader (LKB 5060-006, LKB Instruments, Vienna, Austria) at 540 nm 
and the background at 670 nm was subtracted. The proliferation index was calculated as the 
ratio between proliferation of ConA-stimulated cells and control cells. 
Immunoblot 
CLNC (10
6
) were disrupted in lysis buffer containing 62.5 mM Tris-HCl (pH 6.8, 25°C), 2% 
w/v SDS, 10% glycerol, 50 mM DTT, 0.01% w/v bromophenol blue, and were subjected to 
electrophoresis on a 15% SDS-polyacrylamide gel. All samples were electrotransferred to 
polyvinylidene difluoride membranes at 5 mA/cm
2
, using a semi-dry blotting system (Fastblot 
B43, Biorad, Munich, Germany). The blots were blocked with 5% w/v bovine serum albumin 
(BSA) in PBST buffer (80 mM Na2HPO4; 20 mM NaH2PO4; 100 mM NaCl; 0.1% Tween-20) 
and probed with specific rabbit antibodies raised against -actin (1:500), tubulin (1:500) 
(Abcam, Cambridge, UK) and NUPR1 (1:500) (SantaCruz Biotechnology) in 1% blocking 
buffer, followed by incubation with secondary antibody donkey anti-rabbit HRP at 1:10000 
(GE Healthcare, Buckinghamshire, England) in 1% blocking buffer. Detection was performed 
by the substrate for horseradish peroxidase (HRP), Luminata Crescendo (Milipore 
Corporation, Billerica, AM, USA); photographs were made using X-ray films (Kodak, USA). 
Protein production was calculated by Scion Image Alpha 4.0.3.2 (Scion Corporation, 
Frederick, MD, USA) and was expressed relative to the production of -actin or tubulin. 
RNA isolation, reverse transcription and Real-time PCR  
CLNC were lysed using RNAzol (Metabion, Martinsried, Germany) and RNA was obtained; 
reverse transcription to cDNA and real-time PCR was performed as previously described [13]. 
The primer pairs for -actin were 5'-GACCTGACAGACTACC-3 and 5'-
GGCATAGAGGTCTTTACGG-3' (NM_007393.2); NUPR1 primer pairs were purchased as 
Quantitect Primer Assays from Qiagen (Germantown, MD, USA). NUPR1 mRNA expression 
was calculated according to the formula 2
-(Ct-Cta)
, where Ct is the cycle threshold of the gene of 
interest and Cta is the cycle threshold value of the housekeeping gene (-actin). Data were 
obtained from a real-time PCR apparatus and quantitatively analyzed using SDS 2.1 software 
(Applied Biosystems, Woolston, UK). 
Statistical analysis 
Statistical analysis was performed using the Student’s t test (Statistica 6.0; StatSoft,Inc., 
Tulsa, OK, USA). The results were presented as means±standard deviation (SD); p˂0.05 were 
considered statistically significant. 
 
RESULTS 
The relation of NUPR1 and mitogen-triggered lymphocyte proliferation  
As it has been documented that NUPR1 can be involved in cell proliferation [8], we 
investigated whether NUPR1 expression correlates with lymphocyte proliferation. The 
expansion of lymphocytes was initiated with concanavalin A (ConA), a non-specific T cell 
mitogen that binds and crosslinks components of the T cell receptor, thereby activating 
signaling mechanisms for cell division. ConA indeed stimulated proliferation as judged by the 
MTT assay (0.253±0.086 in control cell cultures vs. 0.510±0.079 in ConA-treated, p=0.019). 
However, when these cells were exposed to ConA for 24 h in optimal culture conditions, the 
expression of NUPR1 mRNA subsided (Fig. 1A). This phenomenon was accompanied by 
lower NUPR1 protein expression (Fig. 1B) after 24 h cultivation with mitogen, suggesting 
that NUPR1 expression and proliferation are inversely correlated. However, attenuation of 
NUPR1 mRNA expression with specific siRNA resulted in impaired ConA-stimulated CLNC 
proliferation (Fig. 1C). This implies that the activity of NUPR1 is probably necessary, at least 
for the initiation of lymphocyte proliferation. Notably, the efficiency of NUPR1 mRNA 
silencing was 100% (Fig. 1D). 
NUPR1 expression correlates with stress-induced apoptosis 
Interestingly, lymphocytes isolated from cervical lymph nodes and immediately tested for the 
presence of apoptotic cells have a small rate of 8% of apoptosis (Fig. 2A). This coincides with 
a relatively high expression of NUPR1 mRNA (Fig. 2B), probably due to stressful events 
during the cell isolation procedure. However, when these cells are placed in a culture plate 
with optimal conditions for their survival, the apoptosis rate increases over time and reaches a 
steady state after 24 h (Fig. 2A). Simultaneously, we tested NUPR1 mRNA expression and 
found that its expression transiently increases up to 6 h and then subsides after 24 h (Fig. 2B). 
Seemingly, the NUPR1 expression precedes apoptosis in lymphocytes. Also, the presence of 
the NUPR1 protein (Fig. 2C) correlates well with the expression of mRNA. What is more, 
lymphocyte apoptosis induced by staurosporine (an antibiotic that unselectively inhibits 
protein kinases by blocking the ATP-binding domain; Fig. 2D) leads to an increase in NUPR1 
mRNA and protein expression (Fig. 2 E, F), suggesting a positive correlation between 
NUPR1 action and apoptosis induction. 
NUPR1 does not promote apoptosis in T lymphocytes 
In order to confirm the suggested role of NUPR1 in apoptosis induction in lymphocytes, 
NUPR1 mRNA was blocked using siRNA. When NUPR1 was inhibited, staurosporine was 
not as efficient in inducing apoptosis as when NUPR1 was active (Fig. 3A). However, when 
we isolated CD3
+
 cells, staurosporine provoked apoptosis of these cells, as in the control 
cultures (Fig. 3B), suggesting that NUPR1 is not mandatory for apoptosis induction in T 
lymphocytes. 
 
DISCUSSION 
Our study has revealed that NUPR1 could have a role in the initiation of lymphocyte 
proliferation stimulated by mitogen as well as in apoptosis induction of non-T cells in the 
lymph nodes of C57BL/6 mice. NUPR1 expression is usually high in tumor cells and it is 
thought that it stimulates their proliferation and drug resistance. However, it might have an 
opposite role in normal, non-transformed somatic cells since its deletion enables the rapid 
proliferation of pancreatic beta cells [8]. In this study, two opposing results were obtained: 
attenuation of NUPR1 impaired lymphocyte proliferation, but also, NUPR1 expression was 
significantly lower 24 h after the administration of mitogen. Seemingly, NUPR1 might be 
mandatory for the initiation of proliferation, but it is not needed for subsequent steps of cell 
division and therefore its expression subsides. The observed lower NUPR1 expression after 
ConA stimulation cannot be an artifact since the non-treated mixed lymphocyte population in 
the culture increase their NUPR1 expression compared to the baseline level detected 
immediately after cell isolation from the lymph nodes. This upregulation of NUPR1 is 
probably related to the initiation of cell apoptosis due to cell manipulations during the 
isolation procedure. It is remarkable that CLNC kept in the optimal conditions for their 
survival, exhibit around 30% of apoptosis after 24 h in culture. In addition, apoptosis 
induction by staurosporine also stimulates NUPR1 expression. This is, however, in conflict 
with data obtained from the cervical cancer cell line (HeLa cells), where NUPR1 binds the 
anti-apoptotic protein prothymosin α and blocks staurosporine-induced apoptosis [2]. The 
observed discrepancy in the relation between induced apoptosis and NUPR1 expression could 
be in the nature of the investigated cells, meaning that immortalized cells have a different 
physiology and thus NUPR1 might have a different function. The final proof that NUPR1 is 
actually related to CLNC apoptosis induction was obtained from the experiments where 
NUPR1 expression was inhibited by specific siRNA that interfered with translation of the 
NUPR1 protein. The observed reduction in cell apoptosis in the absence of NUPR1 clearly 
suggests that NUPR1 is mandatory for the initiation of apoptosis by staurosporine. However, 
CD3
+
 cells were not protected from apoptosis induction when NUPR1 was absent. Although 
our results do not imply an anti-apoptotic role of NUPR1, Weis et al. [11] suggested that 
NUPR1 functions as a blocker of CD3
+
 lymphocyte apoptosis since in both physiological 
conditions and after induction of inflammation, NUPR1 deletion coincides with increased 
CD3
+
 apoptosis. Due to experimental restrictions we were not able to identify the possible 
immune cell population in the lymph node that requires NUPR1 expression for initiation of 
the apoptotic process, but it can be speculated that these might be B lymphocytes that 
represent the second predominant population in cervical lymph nodes (around 30%). This 
percentage actually coincided with the usual number of B cells in cervical lymph nodes in 
healthy animals (our unpublished results). Indeed, it was shown that B cells can succumb to 
staurosporine-induced apoptosis in vitro [14]. Staurosporine is a broad-spectrum protein 
kinase inhibitor and it initiates apoptosis in both normal and transformed cells [15,16]. 
Although we cannot ignore the fact that NUPR1 is important for the execution of apoptosis in 
other immune cell populations present in lymph nodes, such as dendritic cells (1.5-2.5%), 
macrophages (3-4%) and NK cells (1-2.5%), these cells are relatively low in number, and 
their participation in the obtained amount of apoptotic cells is probably negligible. 
Finally, it can be concluded that NUPR1 is important for initiation of the proliferation 
of T cells and the initiation and propagation of apoptosis in immune cells other than T 
lymphocytes. 
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Figure Legends 
 
Fig. 1. The role of NUPR1 in T cell proliferation. Cervical lymph node cells were incubated 
for 24 h with ConA. A – NUPR1 mRNA expression estimated by real-time PCR. B – NUPR1 
protein expression estimated by immunobloting. The results are the means from three 
experiments. NUPR1 expression was attenuated by siRNA NUPR1 and cells were treated 
with ConA for 24 h prior to the MTT assay. C – Results of cell proliferation displayed as the 
proliferation index (the ratio of ConA-treated cells and control cells). D – the efficiency of 
NUPR1 silencing. * denotes p<0.05 between ConA-treated and untreated cells (0). 
 
Fig. 2. The role of NUPR1 in immune cell apoptosis. Cervical lymph node cells were either 
tested immediately after isolation (0 h) or kept in RPMI-1640 and 5% FBS medium in the 
incubator for 6 h or 24 h. A – Apoptosis detected by the determination of caspase activity 
(flow cytometry). B – NUPR1 mRNA expression determined by real-time PCR. C – NUPR1 
protein expression estimated by immunoblotting. A representative blot is displayed adjacent 
to the graph. D – Cervical lymph node cells treated with staurosporine (1 μM); apoptosis was 
determined by annexin-FITC staining immediately after isolation (0 h) or 3 h after the 
treatment. E – NUPR1 mRNA expression and F – NUPR1 protein expression 1 h and 3 h 
after staurosporine administration. The results of one representative experiment out of three 
with similar results are displayed. * denotes p<0.05 between values detected in cells at time 
points 6 h and 24 h vs. 0 h (A, B, C), or 3 h vs, 0 h (D, E, F); # denotes p<0.05 between 
values detected in staurosporine-treated vs. untreated cells. 
 
Fig. 3. NUPR1 is not mandatory for apoptosis in CD3
+
 lymphocytes. Cervical lymph node 
cells were treated with control or NUPR1 siRNA and apoptosis was induced with 
staurosporine (1 μM). After 3 h of incubation cells with active caspases were detected by flow 
cytometry (Apostat) (A). CD3
+
 cells were isolated from cervical lymph node cells, treated 
with control or NUPR1 siRNA, and then incubated for 3 h with staurosporine (1 μM). 
Apoptosis was detected by measuring the percentage of cells with active caspases by flow 
cytometry (Apostat) (B). Results are displayed as the fold increase compared to the values 
measured in untreated cells (0) and are the means from three experiments. * denotes p<0.05 
between values detected in staurosporine-treated cells vs. untreated cells. 
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